The US Food and Drug Administration has given de novo authorization to Memic Innovative Surgery’s Hominis Surgical System as a first-of-its-kind transvaginal robotic hysterectomy device. According to business analysts, the device stands apart as the first miniaturized humanoid robotic platform that allows 360-degree articulation and a small footprint at a potentially low cost.
On 1 March, the FDA announced it has authorized the robotically assisted surgical device (RASD) to remove uteruses in benign...